Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Immix Biopharma, Inc. (IMMX)

NASDAQ

$13.91

$+0.07

(+0.51%)

Previous Close: ⁦$13.83⁩

Market Closed

Immix Biopharma, Inc. (IMMX) Live Price Chart

Last updated: ⁦2026-09-07 21:16:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Immix Biopharma, Inc. (IMMX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $13.91, with a market capitalization of $990.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.94 to $15.10. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$990.25M
Open	$13.68
Day's High	$15.10
Day's Low	$0.68
Previous Close	$13.83
Volume	968.24K
Average Volume	1.83M
P/E Ratio	--
52-Week High	$15.10
52-Week Low	$1.94
Dividend Yield	--
Earnings Date	--

Immix Biopharma, Inc. (IMMX) Latest Closing Stock Price

Immix Biopharma, Inc. (IMMX) last closed at $13.83 as of 2026-09-04 23:31:00, unchanged from the previous close of $13.83.

During the latest regular trading session, IMMX traded between $0.68 and $15.10, with a volume of 968.24K shares. The closing price was near the upper end and near the upper end of its 52-week range.

Immix Biopharma, Inc. (IMMX) 7-Day Stock Price Change

Over the past seven days, Immix Biopharma, Inc. (IMMX) moved from $14.31 to $13.91, representing a decline of 2.83% ($0.41).

The stock traded between $13.42 and $14.61 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.27 million shares, down versus the previous seven-day period, indicating lower trading activity.

IMMX 52-Week Price Position

Position in Range: 90.9%

52W Low$1.94

52W High$15.10

IMMX is currently trading at $13.91, placing it 90.9% of the way from its 52-week low of $1.94 to its 52-week high of $15.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Immix Biopharma, Inc. (IMMX)?

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Immix Biopharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	21
Exchange	NASDAQ
Company Website	https://www.immixbio.com

How to Buy Immix Biopharma, Inc. (IMMX) Stock on MEXC

Eligible investors can buy real shares of Immix Biopharma, Inc. (IMMX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IMMX and Place Your Order

Open the RealStocks trading page and search for IMMX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Immix Biopharma, Inc. (IMMX) stock price today?

Immix Biopharma, Inc. (IMMX) is currently trading at $ 13.91, up 0.54% ($0.07) from the previous close of $ 13.83. Intraday prices update in real time during regular trading hours.

2.Is IMMX stock going up or down today?

As of 2026-09-04 23:31:00, IMMX is trading at $ 13.91, up 0.54% ($0.07) from its previous close of $ 13.83. The stock has traded between $ 0.68 and $ 15.10 during today’s regular session. Past price movements do not guarantee future results.

3.What is IMMX pre-market price?

As of 2026-09-04 23:31:00, IMMX is trading at $ 13.95 in pre-market trading, up 0.85% ($0.12) from the previous close of $ 13.83. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IMMX after-hours price?

As of 2026-09-04 23:31:00, IMMX is trading at $ 13.30 in after-hours trading, down 3.83% ($0.53) from the regular-session close of $ 13.83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IMMX stock trading now?

IMMX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IMMX sit relative to its 52-week high and low?

Over the past 52 weeks, IMMX has traded between a low of $ 1.94 and a high of $ 15.10. At $ 13.91, the stock is positioned 90.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Immix Biopharma, Inc. in?

Immix Biopharma, Inc. (IMMX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Immix Biopharma, Inc.'s market capitalization and where is it listed?

Immix Biopharma, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 990.25M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IMMX valued in terms of P/E ratio and EPS?

IMMX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.56. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Immix Biopharma, Inc. pay a dividend?

Immix Biopharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.